These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32626448)

  • 21. Vision of a near future: Bridging the human health-environment divide. Toward an integrated strategy to understand mechanisms across species for chemical safety assessment.
    Rivetti C; Allen TEH; Brown JB; Butler E; Carmichael PL; Colbourne JK; Dent M; Falciani F; Gunnarsson L; Gutsell S; Harrill JA; Hodges G; Jennings P; Judson R; Kienzler A; Margiotta-Casaluci L; Muller I; Owen SF; Rendal C; Russell PJ; Scott S; Sewell F; Shah I; Sorrel I; Viant MR; Westmoreland C; White A; Campos B
    Toxicol In Vitro; 2020 Feb; 62():104692. PubMed ID: 31669395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The integration of the adverse outcome pathway framework to radiation risk assessment.
    Chauhan V; Stricklin D; Cool D
    Int J Radiat Biol; 2021; 97(1):60-67. PubMed ID: 32397918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk assessment of 'endocrine substances': guidance on identifying endocrine disruptors.
    Lewis RW
    Toxicol Lett; 2013 Dec; 223(3):287-90. PubMed ID: 24036001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?
    Coady K; Browne P; Embry M; Hill T; Leinala E; Steeger T; Maślankiewicz L; Hutchinson T
    Integr Environ Assess Manag; 2019 Jul; 15(4):633-647. PubMed ID: 30908812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of new scientific developments in regulatory risk assessments: challenges and opportunities.
    Tarazona JV
    Integr Environ Assess Manag; 2013 Jul; 9(3):e85-91. PubMed ID: 23625625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of endocrine disruptors: approaches, issues, and uncertainties.
    Chen CW
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():20-3. PubMed ID: 11820607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment.
    Parish ST; Aschner M; Casey W; Corvaro M; Embry MR; Fitzpatrick S; Kidd D; Kleinstreuer NC; Lima BS; Settivari RS; Wolf DC; Yamazaki D; Boobis A
    Regul Toxicol Pharmacol; 2020 Apr; 112():104592. PubMed ID: 32017962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of three approaches for regulatory decision making on pesticides with endocrine disrupting properties.
    Marx-Stoelting P; Niemann L; Ritz V; Ulbrich B; Gall A; Hirsch-Ernst KI; Pfeil R; Solecki R
    Regul Toxicol Pharmacol; 2014 Dec; 70(3):590-604. PubMed ID: 25239592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OECD approaches and considerations for regulatory evaluation of endocrine disruptors.
    Browne P; Van Der Wal L; Gourmelon A
    Mol Cell Endocrinol; 2020 Mar; 504():110675. PubMed ID: 31830512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human exposure to chemical mixtures: Challenges for the integration of toxicology with epidemiology data in risk assessment.
    Hernández AF; Tsatsakis AM
    Food Chem Toxicol; 2017 May; 103():188-193. PubMed ID: 28285934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?
    Marty S; Beekhuijzen M; Charlton A; Hallmark N; Hannas BR; Jacobi S; Melching-Kollmuss S; Sauer UG; Sheets LP; Strauss V; Urbisch D; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2021 Apr; 51(4):328-358. PubMed ID: 34074207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments.
    Corley RA; Mast TJ; Carney EW; Rogers JM; Daston GP
    Crit Rev Toxicol; 2003; 33(2):137-211. PubMed ID: 12708613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health.
    Stucki AO; Barton-Maclaren TS; Bhuller Y; Henriquez JE; Henry TR; Hirn C; Miller-Holt J; Nagy EG; Perron MM; Ratzlaff DE; Stedeford TJ; Clippinger AJ
    Front Toxicol; 2022; 4():964553. PubMed ID: 36119357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.
    Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ENDpoiNTs Project: Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity.
    Lupu D; Andersson P; Bornehag CG; Demeneix B; Fritsche E; Gennings C; Lichtensteiger W; Leist M; Leonards PEG; Ponsonby AL; Scholze M; Testa G; Tresguerres JAF; Westerink RHS; Zalc B; Rüegg J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Building scientific confidence in the development and evaluation of read-across.
    Patlewicz G; Ball N; Boogaard PJ; Becker RA; Hubesch B
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):117-33. PubMed ID: 25857293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of adverse effects in 21st century toxicology.
    Keller DA; Juberg DR; Catlin N; Farland WH; Hess FG; Wolf DC; Doerrer NG
    Toxicol Sci; 2012 Apr; 126(2):291-7. PubMed ID: 22262567
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.